PhaseV Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Employee Data

  • PhaseV has 30 Employees.(i)
  • PhaseV grew their employee count by 43% last year.

PhaseV's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M8-20%N/AN/A
#4
$25.7M13820%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M41-2%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M192-7%N/AN/A
Add Company

What Is PhaseV?

PhaseV is leveraging cutting-edge algorithms such as reinforcement learning and causal ML for adaptive trial design and closed-loop execution, in order to improve trial success rate while maximizing resource and time efficiency. Our novel methodology and advanced technology also enable the detection of hidden signals in data while analyzing clinical trial results and extracting actionable insights.

keywords:N/A

N/A

Total Funding

30

Number of Employees

N/A

Revenue (est)

43%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.9M3011%N/A
#2
$7.8M30-17%N/A
#3
$3.2M303%$4M
#4
$3.6M30-6%$109.1M
#5
$3.5M30N/AN/A